12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Silence Therapeutics management update

Silence Therapeutics plc (LSE:SLN), London, U.K.
Business: Cancer, Renal,...

Read the full 22 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >